CN104825643A - Traditional Chinese medicine composition for treating eczema - Google Patents
Traditional Chinese medicine composition for treating eczema Download PDFInfo
- Publication number
- CN104825643A CN104825643A CN201510217871.3A CN201510217871A CN104825643A CN 104825643 A CN104825643 A CN 104825643A CN 201510217871 A CN201510217871 A CN 201510217871A CN 104825643 A CN104825643 A CN 104825643A
- Authority
- CN
- China
- Prior art keywords
- parts
- eczema
- chinese medicine
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating eczema. The traditional Chinese medicine composition comprises, by weight, 5 to 7 parts of raw rehmannia root, 5 to 7 parts of fleece-flower root, 7 to 9 parts of Chinese angelica, 8 to 10 parts of Scrophularia henryi Hemsl., 8 to 10 parts of stir-fried fructus tribuli, 8 to 10 parts of stir-fried muscardine silkworm, 2 to 4 parts of turpentine, 2 to 4 parts of safflower, 5 to 8 parts of bighead atractylodes rhizome and 2 to 5 parts of Poria cocos. The traditional Chinese medicine composition treats eczema with traditional Chinese medicine, has no side-effect, is convenient to carry and take, thoroughly cures eczema and has the advantages of no side-effect, strong targeting capacity and substantial curative effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of eczema, belong to technical field of Chinese medicines.
Background technology
Eczema is a kind of allergic skin disease of common easy recurrence, is apt to occur in women's head-ornaments, extremity bend the positions such as side, normal in general or symmetry distribution, usually itches pain unbearably, repeatedly oozes out time serious.
Current treatment eczema adopts the medicine containing 17-hydroxy-11-dehydrocorticosterone to wipe mostly outward, this can select for mild or the smaller eczema of scope, but for the eczema of large-area eczema or recurrent exerbation, if frequent long-term a large amount of medicine used containing 17-hydroxy-11-dehydrocorticosterone, skin can be made to produce drug dependence, once drug withdrawal, eczema of again showing effect is more serious sometimes.
Summary of the invention
For the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of eczema, adopt treatment by Chinese herbs, have no side effect, be convenient for carrying and take, thoroughly can cure eczema, not any side effect, specific aim is extremely strong, evident in efficacy.
Treat a Chinese medicine composition for eczema, be made up of following raw material medicaments in part by weight: Radix Rehmanniae 5-7 part, Radix Polygoni Multiflori 5-7 part, Radix Angelicae Sinensis 7-9 part, black ginseng 8-10 part, fries Fructus Atriplicis Sibiricae 8-10 part, Bombyx Batryticatus (parched) 8-10 part, Colophonium 2-4 part, Flos Carthami 2-4 part, Rhizoma Atractylodis Macrocephalae 5-8 part, Poria 2-5 part.
Preferably, the Chinese medicine composition of described treatment eczema, is made up of following raw material medicaments in part by weight: Radix Rehmanniae 6 parts, Radix Polygoni Multiflori 6 parts, Radix Angelicae Sinensis 8 parts, black ginseng 9 parts, fries Fructus Atriplicis Sibiricae 9 parts, Bombyx Batryticatus (parched) 9 parts, 3 parts, Colophonium, 3 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 7 parts, 3 parts, Poria.
Effect of described crude drug is as follows:
Effect that Radix Rehmanniae has clearing away heat and cooling blood, tonifying YIN promotes the production of body fluid, contain for heat in blood poison, macule purple is black, and interior-heat is quenched one's thirst.
Radix Polygoni Multiflori has nourishing the blood and yin, fills out beneficial vital essence, takes a tonic or nourishing food to build up one's health Kidney-Yin effect.
Chinese angelica blood supplementing is invigorated blood circulation, nourish QI and blood.
Black ginseng has supplementing QI and nourishing YIN, effect of pain relieving.
Fructus Atriplicis Sibiricae, suppressing the hyperactive liver resolving depression, dispelling pathogenic wind for improving eyesight, for the disease such as hypochondriac pain due to stagnation of liverQI, skin pruritus, frying Fructus Atriplicis Sibiricae is Fructus Atriplicis Sibiricae decontamination, fries to micro-yellow, grinds deburring.
Bombyx Batryticatus (parched), acrid in the mouth, property is put down, and has expelling wind to relieve convulsion, dissipating phlegm and resolving masses, effect of heat-clearing and toxic substances removing dampness.
Colophonium has dispeiling pathogenic wind and removing dampness, evacuation of pus of drawing out pus by applying a plaster to the affected part, effect of granulation promoting pain relieving.
Flos Carthami has promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing, effect of speckle rash stasis.
Rhizoma Atractylodis Macrocephalae invigorating middle warmer dampness, slakes thirst and help produce saliva, most strengthening the spleen essence.
Poria removing dampness and detoxicating, easing joint movement.
The present invention utilizes the clearing away heat and cooling blood of Radix Rehmanniae, Radix Polygoni Multiflori, Radix Angelicae Sinensis, Flos Carthami, effect of invigorating blood circulation of enriching blood, be aided with black ginseng, fry Fructus Atriplicis Sibiricae pain relieving, recycling Bombyx Batryticatus (parched), Colophonium, the Rhizoma Atractylodis Macrocephalae, effect of the heat-clearing and toxic substances removing dampness of Poria, each component synergism, to reach the effect of heat-clearing and toxic substances removing damp eliminating, cooling blood, expelling wind, antalgesic-antipruritic.
The preparation method of the Chinese medicine composition of described treatment eczema, concrete steps are as follows:
Prescription crude drug is pulverized in proportion, crosses 800-1000 mesh sieve, when taking, the medicated powder 60g boiled water sieved is melted, sooner or later take, 7 days courses for the treatment of.
The Chinese medicine composition for the treatment of eczema of the present invention, adopts treatment by Chinese herbs, has no side effect, be convenient for carrying and take, thoroughly can cure eczema, and not any side effect, specific aim is extremely strong, evident in efficacy.
Detailed description of the invention
Embodiment 1
Treat a Chinese medicine composition for eczema, be made up of following raw material medicaments in part by weight: Radix Rehmanniae 7 parts, Radix Polygoni Multiflori 5 parts, Radix Angelicae Sinensis 7 parts, black ginseng 10 parts, fry Fructus Atriplicis Sibiricae 8 parts, Bombyx Batryticatus (parched) 10 parts, 2 parts, Colophonium, 2 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 6 parts, 4 parts, Poria.
Prescription crude drug is pulverized in proportion, crosses 800-1000 mesh sieve, when taking, the medicated powder 60g boiled water sieved is melted, sooner or later take, 7 days courses for the treatment of.
Embodiment 2
Treat a Chinese medicine composition for eczema, be made up of following raw material medicaments in part by weight: Radix Rehmanniae 6 parts, Radix Polygoni Multiflori 6 parts, Radix Angelicae Sinensis 8 parts, black ginseng 9 parts, fry Fructus Atriplicis Sibiricae 9 parts, Bombyx Batryticatus (parched) 9 parts, 3 parts, Colophonium, 3 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 7 parts, 3 parts, Poria.
Prescription crude drug is pulverized in proportion, crosses 800-1000 mesh sieve, when taking, the medicated powder 60g boiled water sieved is melted, sooner or later take, 7 days courses for the treatment of.
Embodiment 3
Treat a Chinese medicine composition for eczema, be made up of following raw material medicaments in part by weight: Radix Rehmanniae 5 parts, Radix Polygoni Multiflori 7 parts, Radix Angelicae Sinensis 9 parts, black ginseng 8 parts, fry Fructus Atriplicis Sibiricae 10 parts, Bombyx Batryticatus (parched) 8 parts, 4 parts, Colophonium, 4 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 5 parts, 5 parts, Poria.
Prescription crude drug is pulverized in proportion, crosses 800-1000 mesh sieve, when taking, the medicated powder 60g boiled water sieved is melted, sooner or later take, 7 days courses for the treatment of.
Embodiment 4
Treat a Chinese medicine composition for eczema, be made up of following raw material medicaments in part by weight: Radix Rehmanniae 6 parts, Radix Polygoni Multiflori 6 parts, Radix Angelicae Sinensis 7 parts, black ginseng 10 parts, fry Fructus Atriplicis Sibiricae 8 parts, Bombyx Batryticatus (parched) 10 parts, 2 parts, Colophonium, 4 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 8 parts, 2 parts, Poria.
Prescription crude drug is pulverized in proportion, crosses 800-1000 mesh sieve, when taking, the medicated powder 60g boiled water sieved is melted, sooner or later take, 7 days courses for the treatment of.
Clinical practice test example:
The routine patient of clinical Stochastic choice 100, all patients are eczema, wherein acute eczema 40 example, subacute eczema 30 example, chronic eczema 30 example.
Therapeutic Method: melted by medicine 60g boiled water of the present invention, takes, 7 days courses for the treatment of sooner or later.
Diagnostic criteria:
The clinical manifestation of acute eczema for morbidity anxious, local skin is from the beginning of erythema, and flushing, swelling, then erythema occurs being dispersed in or intensive pimple or chickenpox, sepage stream Tianjin, pruritus is endlessly.Subacute eczema after acute eczema symptom alleviates, or acute stage do not process in time, to stall for time comparatively for a long time and to occur, skin lesion is based on little pimple, squama and incrustation, only there are minority papulovesicle or vesicle and erosion, also can have mild infiltration, consciously still have violent pruritus.The clinical manifestation of chronic eczema is that illing skin infiltration thickens, and become kermesinus and pigmentation, skin lesion stricture of vagina is greatly thicker, mostly is limitation speckle.
Outcome measure: clinical cure is that skin lesion disappears completely or only stays pigmentation, subjective symptoms disappears; Effectively disappear more than 70% for skin lesion, subjective symptoms alleviates or disappears; Effectively for skin lesion disappears more than 30%, subjective symptoms alleviates; Invalidly to disappear less than 30% for skin lesion.
Treat 100 routine patients altogether, its therapeutic effect sees the following form:
Cure | Effective | Effectively | Invalid | |
Embodiment 1 | 97 | 2 | 1 | 0 |
Embodiment 2 | 98 | 1 | 1 | 0 |
Embodiment 3 | 96 | 2 | 2 | 0 |
Embodiment 4 | 97 | 2 | 1 | 0 |
As can be seen from the above table, adopt Chinese medicine composition of the present invention to treat eczema, its totall effective rate in clinical treatment is 100%, wherein best with the therapeutic effect of embodiment 2.
Claims (2)
1. treat a Chinese medicine composition for eczema, it is characterized in that: be made up of following raw material medicaments in part by weight: Radix Rehmanniae 5-7 part, Radix Polygoni Multiflori 5-7 part, Radix Angelicae Sinensis 7-9 part, black ginseng 8-10 part, fries Fructus Atriplicis Sibiricae 8-10 part, Bombyx Batryticatus (parched) 8-10 part, Colophonium 2-4 part, Flos Carthami 2-4 part, Rhizoma Atractylodis Macrocephalae 5-8 part, Poria 2-5 part.
2. treat the Chinese medicine composition of eczema according to claim 1, it is characterized in that: be made up of following raw material medicaments in part by weight: Radix Rehmanniae 6 parts, Radix Polygoni Multiflori 6 parts, Radix Angelicae Sinensis 8 parts, black ginseng 9 parts, fries Fructus Atriplicis Sibiricae 9 parts, Bombyx Batryticatus (parched) 9 parts, 3 parts, Colophonium, 3 parts, Flos Carthami, the Rhizoma Atractylodis Macrocephalae 7 parts, 3 parts, Poria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510217871.3A CN104825643A (en) | 2015-04-30 | 2015-04-30 | Traditional Chinese medicine composition for treating eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510217871.3A CN104825643A (en) | 2015-04-30 | 2015-04-30 | Traditional Chinese medicine composition for treating eczema |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104825643A true CN104825643A (en) | 2015-08-12 |
Family
ID=53804093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510217871.3A Pending CN104825643A (en) | 2015-04-30 | 2015-04-30 | Traditional Chinese medicine composition for treating eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104825643A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784333A (en) * | 2012-08-20 | 2012-11-21 | 王军红 | Traditional Chinese medicine composition for curing eczema |
CN104398915A (en) * | 2014-12-07 | 2015-03-11 | 唐云峰 | Traditional Chinese medicinal composition for chronic eczema |
-
2015
- 2015-04-30 CN CN201510217871.3A patent/CN104825643A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784333A (en) * | 2012-08-20 | 2012-11-21 | 王军红 | Traditional Chinese medicine composition for curing eczema |
CN104398915A (en) * | 2014-12-07 | 2015-03-11 | 唐云峰 | Traditional Chinese medicinal composition for chronic eczema |
Non-Patent Citations (2)
Title |
---|
瞿幸: "中医辨证治疗湿疹85例", 《中医杂志》 * |
鲍学全等: "《疑难病中医治疗及研究》", 31 October 1995 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
CN102284028B (en) | Medicine for treating rheumatoid arthritis | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN103877517A (en) | Traditional Chinese medicine for treating pneumonia | |
CN103656462B (en) | One treats neurasthenic Chinese medicine | |
CN103316192A (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
CN103845429A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN103705850B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
CN102836395A (en) | Traditional Chinese medicine composition used for treating dysmenorrhea | |
CN103341013B (en) | A kind of Chinese medicine for the treatment of lumbago and skelalgia | |
CN103301328B (en) | Trigeminal neuralgia treatment medicine | |
CN102078432A (en) | Medicament for treating skin itch | |
CN103330798A (en) | Traditional Chinese medicinal preparation for treating rheumatisms | |
CN1181879C (en) | Analgestic plaster | |
CN104825643A (en) | Traditional Chinese medicine composition for treating eczema | |
CN103690833B (en) | A kind of Chinese medicine for the treatment of rheumatic arthritis | |
CN102824608A (en) | Externally used Chinese herba preparation for treating peripheral vascular disease | |
CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN103768366B (en) | Traditional Chinese medicine preparation for treating proliferation of mammary gland | |
CN104189626A (en) | Traditional Chinese medicine used for treating eczema | |
CN104707053A (en) | Traditional Chinese medicine composition for curing cervicitis | |
CN103736013A (en) | Traditional Chinese medicine for treating tuberculosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150812 |